Skip to main content
Article
Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020.
Journal of Clinical Oncology (2017)
  • Howard Kaufman, Yeshiva University
  • Jose Lutzky, Mount Sinai Hospital
  • Joseph Clark, Loyola University Chicago
  • Kim Allyson Margolin, City of Hope National Medical Center
  • David H. Lawson, Emory University
  • Asim Amin, Carolinas Healthcare System
  • Frances A. Collichio, University of North Carolina at Chapel Hill
  • Andrew Pecora, Hackensack University Medical Center
  • Walter John Urba
  • Kelly L. Bennett
  • David F. McDermott, Harvard University
Publication Date
January 30, 2017
Citation Information
Howard Kaufman, Jose Lutzky, Joseph Clark, Kim Allyson Margolin, et al.. "Safety and efficacy of ipilimumab in melanoma patients who received prior immunotherapy on phase III study MDX010-020." Journal of Clinical Oncology (2017)
Available at: http://works.bepress.com/walter-urba/102/